India, Jan. 29 -- With the Union Budget 2025 on the horizon, BioSpectrum India hosted a pre-budget session virtuallyled by CEO Manasee Kurlekar, featuring esteemed industry leaders Dr. rer. nat. Nagaraj Rao, Managing Director of Rane Rao Reshamia Laboratories Pvt Ltd, and Dr. Chandrashekharan S, Chairman & Managing Director of Vipragen Biosciences

The discussion focused on India's GDP trajectory, innovation-driven biotech growth, healthcare infrastructure, talent retention, and policy expectations from the upcoming budget.

India's GDP Growth & Competitive Landscape

Kicking off the session, Dr. Nagaraj Rao provided an economic outlook, stating that India's GDP growth is projected between 6% to 7.5% in 2025. He highlighted that while Ind...